These are the only drugs providing radical cure of vivax malaria (prevention of relapse), but they are underused because G6PD deficiency testing is usually not available and prescribers are naturally concerned about precipitating dangerous haemolysis. The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.